Advanced Biomed is trading at $7.57 (5.4% down) in after-hours trading as the selloff extends following the cancellation of its planned securities offering.

  • The stock has lost more than half its value over the past week as the multi-day decline intensifies.
  • Investors are increasingly concerned about the company’s financing uncertainty following the canceled offering.
  • The selloff persists despite a generally firm tone in the broader market.